Sun Changquan Calvin
Amgen Inc., Materials Science Laboratory, Small Molecule Pharmaceutics, One Amgen Center Dr. 21-2-A, Thousand Oaks, California 91320, USA.
J Pharm Sci. 2007 May;96(5):1043-52. doi: 10.1002/jps.20928.
True density is a physical property of both fundamental and practical importance to the study of pharmaceutical powders. True density may be calculated from crystal structure. However, precision of such calculated density is not well understood. Furthermore, thermal expansion properties of organic crystals have rarely been characterized. A survey of Cambridge Crystal Database is conducted to assess (1) precision of calculated crystal density from crystal structure; (2) thermal expansion properties of organic crystals. It is shown that calculated crystal density exhibits, on average, a relative standard deviation (RSD) of approximately 0.4%. It is found that crystal density generally increases linearly with decreasing temperature provided no phase change occurs. Slope of the line, termed thermal density gradient, of organic crystals ranges between 0.04 and 1.74 mg cm(-3) K(-1) with an average of approximately 0.2 mg cm(-3) K(-1). It is shown that majority polymorph pairs exhibit significantly different thermal expansion behavior and their density-temperature lines can cross. This likely contributes to the less than perfect prediction of relative stability of polymorphs at ambient temperature using the density rule.
真密度是药物粉末研究中具有基础重要性和实际重要性的物理性质。真密度可根据晶体结构计算得出。然而,这种计算密度的精度尚未得到很好的理解。此外,有机晶体的热膨胀特性很少被表征。对剑桥晶体数据库进行了一项调查,以评估:(1)根据晶体结构计算晶体密度的精度;(2)有机晶体的热膨胀特性。结果表明,计算得到的晶体密度平均相对标准偏差(RSD)约为0.4%。研究发现,只要不发生相变,晶体密度通常随温度降低呈线性增加。有机晶体的直线斜率(称为热密度梯度)在0.04至1.74 mg cm⁻³ K⁻¹之间,平均约为0.2 mg cm⁻³ K⁻¹。结果表明,大多数多晶型物对表现出显著不同的热膨胀行为,并且它们的密度-温度线可能交叉。这可能导致使用密度规则对室温下多晶型物相对稳定性的预测不够完美。